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Research
Chronic kidney disease (CKD) is an increasing 
public health problem worldwide, resulting in 
substantial morbidity and mortality related to 
cardiovascular disease and end-stage renal dis-
ease (Coresh et al. 2007; Meguid El Nahas and 
Bello 2005). Established risk factors for CKD 
include diabetes (Triyanti et al. 2008), hyper-
tension (Hajjar and Kotchen 2003; Rossert 
and Wauters 2002), and metabolic syndrome 
(Ryu et al. 2009). In addition, environmental 
exposures, including toxic metals, are poten-
tially important CKD risk factors that have 
been understudied in general populations 
(Muntner et al. 2003; Navas-Acien et al. 2009). 
Cadmium, a widely distributed metal in the 
environment, is a well-known nephrotoxicant 
at high levels of exposure (Järup et al. 1995; 
Nordberg et al. 2007). Recent epidemiologic 
evidence from the United States and other 
countries also supports cadmium-related neph-
rotoxicity at relatively low levels of exposure 
(Åkesson et al. 2005; Chen et al. 2006; Ferraro 
et al. 2010; Hellström et al. 2001; Jin et al. 
2004; Navas-Acien et al. 2009; Thomas et al. 
2009). Data on associations between low-level 
cadmium exposure and estimated glomerular 
filtration rate (eGFR), however, remain scarce.
The objective of this study was to evaluate 
associations of blood cadmium with eGFR in 
South Korean adults who participated in the 
2005 Korean National Health and Nutrition 
Examination Survey (KNHANES III). This 
is a particularly relevant population because 
almost 7% of South Korean adults have 
eGFR < 60 mL/min per 1.73 m2 based on the 
Modification of Diet Renal Disease (MDRD) 
Study equation (Jang et al. 2010), and cadmium 
exposure may be more common than in other 
countries because of soil contamination from 
metal mining and smelting processes in South 
Korea (Hong et al. 2009; Jung 2008; National 
Institute of Agricultural Science and Technology 
1997). Major sources of cadmium in the general 
population of Korea include dietary intake (e.g., 
rice, vegetables) due to uptake from contami-
nated soil, and smoking (Eunha et al. 2006; Lee 
et al. 1986; Moon et al. 1995). Indeed, blood 
cadmium levels measured in a representative 
sample of South Korean adults were markedly 
higher than levels measured in a representative 
sample of U.S. adults (Kim and Lee 2011).
Materials and Methods
Study population. KNHANES III was con-
ducted by the Korean Ministry of Health and 
Welfare in 2005 using a stratified, multistage, 
probability cluster sampling design to select 
a representative sample of the South Korean 
population. Based on the 2000 National 
Census Registry, KNHANES randomly 
selected 600 sampling units for health inter-
views and 200 of those for health examina-
tions, from 246,097 primary sampling units, 
each consisting of approximately 60 house-
holds. The participation rate for the health 
examination was 70.2% (7,597 participants). 
Among 5,501 participants ≥ 20 years of age, 
KNHANES randomly selected 10–12 subjects 
from each sampling unit while maintaining 
a uniform distribution across gender and five 
age groups (20–29, 30–39, 40–49, 50–59, 
≥ 60 years) to yield a total of 1,998 subjects to 
measure lead, cadmium, and mercury in whole 
blood. We excluded 12 pregnant women, 
3 participants missing serum creatinine, 20 
participants missing height, weight, or other 
biochemistry variables, and 54 participants 
missing questionnaire responses for tobacco 
or alcohol consumption, leaving 1,909 par-
ticipants for this study. The study design was 
approved by the Institutional Review Board 
of the Soonchunhyang University, College of 
Medicine. All participants provided written, 
informed consent.
Blood cadmium and lead. Blood samples 
for metal analysis were drawn into trace-metal–
free tubes. The Seoul Medical Science Institute 
measured cadmium and lead in whole blood 
using graphite furnace atomic absorption spec-
trometry (model SpectrAA-800, with Zeeman 
correction; Varian Instruments, Agilent 
Technologies, Mulgrave, Australia). The limit 
of detection was 0.30 μg/L for blood cadmium 
and 0.23 μg/dL for blood lead. A total of 
8 (0.4%) and 5 (0.3%) participants had blood 
cadmium and lead levels, respectively, below 
the limit of detection. For those participants, 
we imputed a level equal to the limit of detec-
tion divided by the square root of 2 (Hornung 
and Reed 1990). For internal quality assurance 
and control, standard reference materials were 
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Ba c k g r o u n d: Cadmium is a nephrotoxicant at high exposure levels. Few studies have evaluated the 
role of cadmium in kidney function at low-exposure levels.
oB j e c t i v e: We evaluated the association of blood cadmium with estimated glomerular filtration 
rate (eGFR) in the Korean adult population.
Me t h o d s : We evaluated 1,909 adults ≥ 20 years of age who participated in the 2005 Korean 
National Health and Nutrition Examination Survey and had blood cadmium determinations. eGFR 
was calculated using the Modification of Diet in Renal Disease equation.
re s u l t s: Blood cadmium geometric means were 1.57 μg/L for men and 1.49 μg/L for women. The 
difference in eGFR levels that compared participants in the highest versus lowest cadmium tertiles, 
after multivariable adjustment, was –1.85 [95% confidence interval (CI): –3.55, –0.16] mL/min per 
1.73 m2 in women and 0.67 (–1.16, 2.50) mL/min per 1.73 m2 in men. Among men, the associa-
tion between blood cadmium and eGFR was modified by blood lead levels (p-value for interaction 
= 0.048). The fully adjusted differences in eGFR levels for a 2-fold increase in blood cadmium levels 
were –1.14 (–3.35, 1.07) and 1.84 (0.54, 3.14) mL/min per 1.73 m2 in men with blood lead levels 
below and above the median (2.75 μg/dL), respectively.
co n c l u s i o n: Elevated blood cadmium levels were associated with lower eGFR in women, which 
supports the role of cadmium as a risk factor for chronic kidney disease. In men, there was no over-
all association, although elevated blood cadmium levels were associated with higher eGFR levels in 
men with high blood lead levels and nonstatistically associated with lower eGFR levels in men with 
low blood lead levels.
key w o r d s : cadmium, chronic kidney disease, glomerular filtration rate, Korean, survey. Environ Health 
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obtained from Bio-Rad (Lyphochek® Whole 
Blood Metals Control; Bio-Rad Laboratories, 
Hercules, CA, USA). The interassay coefficients 
of variation ranged from 10.0% to 21.1% for 
three blood cadmium samples with levels 4.30, 
1.11, and 0.37 μg/L and from 7.6% to 8.9% 
for three blood lead samples with levels 48.0, 
26.0, and 8.5 μg/dL. With respect to external 
quality programs, the Seoul Medical Science 
Institute has a certified license from the Korean 
Ministry of Labor as a designated laboratory 
for heavy metal analyses and has passed the 
German External Quality Assessment Scheme 
operated by Friedrich-Alexander-Universität 
Erlangen-Nürnberg. For KNHANES, the 
Korean Institute of Science and Technology 
randomly selected and reanalyzed 30 blood 
samples using graphite furnace atomic absorp-
tion spectrometry. The interlaboratory reliabil-
ity for cadmium (r = 0.73) was lower compared 
with lead (r = 0.91).
Measures of kidney outcomes. KNHANES 
measured serum creatinine with a kinetic Jaffé 
method using an autoanalyzer (model 747; 
Hitachi, Tokyo, Japan). We used the MDRD 
Study equation to estimate eGFR, as an indi-
cator of glomerular function: eGFR (milliliters 
per minute per 1.73 m2) = 186.3 × (serum 
creatinine)–1.154 × (age)–0.203 (× 0.742 if the 
individual was female). The number of par-
ticipants with eGFR levels < 60 mL/min 
per 1.73 m2 was relatively small (36 men and 
84 women, corresponding to weighted preva-
lences for the Korean population of 3.3% and 
8.2%, respectively). For this study, we catego-
rized participants as having reduced eGFR if 
their eGFR levels were below the 25th percen-
tile using sex-specific cutoffs (< 74.7 mL/min 
per 1.73 m2 for men and < 65.4 mL/min per 
1.73 m2 for women).
Other variables. Information on age, sex, 
education, menopause status, smoking, and 
alcohol consumption was based on self-report. 
Urbanization was categorized as metropolitan 
(superior administrative district that includes 
Seoul and six other large cities), urban (other 
cities in Korea), and rural (other localities). 
Body mass index (BMI) was calculated by 
dividing measured weight in kilograms by 
squared measured height in meters. Blood 
pressure was measured three times after 5 min 
of rest during the health examination, using 
a standard mercury sphygmomanometer 
(Baumanometer; W.A. Baum Co. Inc., New 
York, NY, USA). The last two measurements 
were averaged and used to estimate the preva-
lence of hypertension, which was defined as 
mean systolic blood pressure ≥ 140 mmHg, 
mean diastolic blood pressure ≥ 90 mmHg, 
or self-reported antihypertensive medication 
use. Diabetes mellitus was defined as fast-
ing glucose ≥ 126 mg/dL, nonfasting glucose 
≥ 200 mg/dL, or self-reported medication use 
(insulin and oral hypoglycemic treatment).
Statistical analysis. We performed all 
statistical analyses using the svy commands 
in STATA (version 11; StataCorp, College 
Station, TX, USA) to account for the complex 
sampling design and weights in KNHANES 
2005 and to obtain results that are represen-
tative of the South Korean population. The 
distributions of blood cadmium and lead were 
right skewed and were log-transformed for the 
analyses. We categorized blood cadmium levels 
in tertiles, based on weighted distributions in 
the whole study sample. Participant character-
istics by cadmium tertiles were compared using 
p-values for trend based on the Wald test. The 
statistical significance level was set at α = 0.05. 
All statistical analyses were two sided.
We observed significant differences by sex 
in the association between blood cadmium 
and eGFR (p-value for interaction = 0.004). 
Consequently, we conducted all analyses sepa-
rately for men and women. Differences [95% 
confidence intervals (CIs)] in eGFR levels were 
estimated comparing the highest and the sec-
ond highest tertiles to the lowest tertile (base-
line) of blood cadmium using linear regression 
(i.e., tertiles 2 and 3 vs. tertile 1). We also used 
logistic regression to examine odds ratios of 
reduced eGFR (< 74.7 mL/min per 1.73 m2 in 
men, < 65.4 mL/min per 1.73 m2 in women) 
associated with increased blood cadmium levels. 
Statistical models were progressively adjusted 
for age (continuous), education (< high school, 
high school, > high school), living region (met-
ropolitan/urban/rural), BMI (continuous), 
smoking status (never/former/current), alcohol 
intake (never/former/  current), and blood lead 
(log transformed). We observed no substantial 
changes with further adjustments for hyperten-
sion and diabetes status, and these variables 
were not retained in the final models.
We estimated fully adjusted differences 
in eGFR associated with a 2-fold increase in 
blood cadmium levels by sex and in subgroups 
defined by age (< 40, 40–60, > 60 years), 
BMI (< 25, ≥ 25 kg/m2), education (< high 
school, high school, > high school), living 
region (metropolitan, urban, rural), smoking 
status (never, former, current), alcohol intake 
(never, former, current), and blood lead levels 
(below and above the median, 2.75 μg/dL). 
We tested for statistical interactions by includ-
ing the product of log-transformed cadmium 
and each covariate in the regression models.
Results
Participant characteristics. Mean eGFR 
was 81.5 mL/min per 1.73 m2 in men and 
74.4 mL/min per 1.73 m2 in women. Men 
and women with reduced eGFR were older, 
less likely to have more than a high school edu-
cation, and more likely to have hyper  tension 
and diabetes mellitus (Table 1). Women but 
not men with reduced eGFR were more likely 
to have higher blood cadmium and lead levels.
The overall geometric mean of blood cad-
mium was 1.57 μg/L in men and 1.49 μg/L 
in women (data not shown). The overall geo-
metric mean of blood lead was 2.98 μg/dL 
in men and 2.31 μg/dL in women (data not 
shown). Blood cadmium and lead were higher 
Table 1. Participant characteristics by eGFR status and sex, KNHANES 2005.
 Reduced eGFRa
Males Females
Characteristic No (n = 693) Yes (n = 262) No (n = 695) Yes (n = 259)
Age (years) 40.1 ± 0.6 51.0 ± 1.1 40.3 ± 0.7 55.1 ± 0.7
Postmenopauseb 25.1 (2.2) 62.6 (3.4)
Education
< High school 18.4 (1.8) 26.9 (3.0) 29.1 (2.0) 57.4 (3.1)
High school 46.4 (2.2) 43.9 (3.8) 42.7 (2.2) 34.0 (2.7)
> High school 35.2 (2.0) 29.3 (3.5) 28.2 (2.1) 8.6 (1.8)
Region
Metropolitan 40.2 (1.9) 50.1 (4.0) 51.1 (1.9) 44.3 (4.3)
Urban 39.7 (2.1) 35.3 (4.0) 31.5 (1.7) 31.8 (4.1)
Rural 20.0 (1.5) 14.6 (3.0) 17.4 (1.6) 23.9 (3.9)
BMI (kg/m2) 23.9 (0.2) 24.5 (0.2) 23.2 (0.1) 24.2 (0.2)
Smoking status
Never 17.3 (1.8) 13.9 (2.2) 88.7 (1.6) 89.5 (2.2)
Former 31.2 (2.3) 41.4 (3.0) 6.0 (1.2) 3.7 (1.3)
Current 51.6 (2.5) 44.6 (3.1) 5.3 (1.1) 6.8 (1.8)
Alcohol intake
Never 3.5 (0.7) 9.4 (2.3) 14.4 (1.3) 23.3 (3.0)
Former 6.5 (1.1) 10.5 (2.0) 10.8 (1.4) 14.0 (2.4)
Current 90.0 (1.4) 80.1 (2.8) 74.7 (1.9) 62.7 (3.7)
Hypertension 22.0 (1.9) 39.2 (3.3) 13.5 (1.3) 36.8 (3.3)
Diabetes mellitus 6.3 (1.0) 9.8 (1.9) 4.2 (0.8) 8.3 (1.8)
Blood cadmium (μg/L)c 1.59 (1.51, 1.67) 1.52 (1.44, 1.62) 1.45 (1.39, 1.51) 1.65 (1.56, 1.74)
Blood lead (μg/dL)c 3.00 (2.85, 3.15) 2.93 (2.7, 3.18) 2.16 (2.04, 2.29) 2.80 (2.57, 3.06)
Values are mean ± SE or percentage (SE), unless otherwise noted. All values are weighted.
a Males, < 74.7 mL/min per 1.73 m2; females, < 65.4 mL/min per 1.73 m2. bThere were 88 women with missing data for 
menopausal status (n = 866). cGeometric mean (95%CI).Hwangbo et al.
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in men without reduced eGFR and in women 
with reduced eGFR, compared with men with 
reduced eGFR and women without reduced 
eGFR, respectively (Table 1). The weighted 
Pearson’s correlation coefficient between 
blood cadmium and lead levels was –0.05 
(p = 0.12) in men and –0.01 (p = 0.87) in 
women (data not shown). Men who lived 
in the metropolitan city or who were for-
mer smokers or current alcohol drinkers had 
lower blood cadmium levels than did other 
men (p-value for trend < 0.05). For women, 
increasing age, lower education, and lower 
eGFR were associated with higher blood cad-
mium levels, whereas high school education 
was associated with lower blood cadmium 
levels (p-value for trend < 0.05). Increasing 
blood cadmium levels were associated with 
the prevalence of hypertension in both men 
and women (Table 2).
Blood cadmium levels and eGFR. After 
adjustment for sociodemographic factors, 
CKD risk factors and blood lead levels, the 
difference in eGFR levels comparing par-
ticipants in the highest versus the lowest 
tertiles of blood cadmium was 0.67 (95% 
CI: –1.16, 2.50) mL/min per 1.73 m2 
in men and –1.85 (–3.55, –0.16) mL/min 
per 1.73 m2 in women (Table 3, model 3). 
Similar results were found for reduced eGFR 
(Table 4). Fully adjusted odds ratio for 
reduced eGFR (< 74.6 mL/min per 1.73 m2 
in men and < 65.4 mL/min per 1.73 m2 in 
women) comparing the highest versus lowest 
blood cadmium tertiles was 0.75 (95% CI: 
0.49, 1.15) in men and 1.62 (1.00, 2.62) in 
women.
Subgroup analysis. Among women, the 
association between blood cadmium and 
eGFR levels was consistent by all participant 
characteristics evaluated (Table 5). Among 
men, the association between blood cadmium 
and eGFR was modified by blood lead levels 
(p-value for interaction = 0.048) and educa-
tion (p-value for interaction = 0.026), and 
maybe by alcohol intake (p-value for inter-
action = 0.052). The fully adjusted difference 
in eGFR levels for a 2-fold increase in blood 
cadmium levels in men was –1.14 (95% CI: 
–3.35, 1.07) mL/min per 1.73 m2 for blood 
lead ≤ 2.75 μg/dL and 1.84 (0.54, 3.14) 
mL/min per 1.73 m2 for blood lead > 2.75 
μg/dL (Table 5). Similarly, the difference in 
eGFR levels comparing the highest to the 
lowest cadmium tertile for men with blood 
lead levels below and above 2.75 μg/dL 
were –2.01 (95% CI: –5.43, 1.41) and 2.47 
(0.41, 4.53) mL/min per 1.73 m2, respec-
tively. The odds ratio for eGFR < 74.7 
mL/min per 1.73 m2 comparing the high-
est to the lowest cadmium tertile for men 
with blood lead levels below and above 2.75   
μg/dL were 1.30 (95% CI: 0.64, 2.64) and 
0.56 (0.33, 0.93), respectively. By education, 
blood cadmium levels were positively associ-
ated with eGFR levels in men with more than 
a high school education but not in men with 
a high school education or less. By alcohol 
intake, blood cadmium   levels were positively 
associated with eGFR levels, but effect modi-
fication was borderline   statistically significant.
Discussion
In a representative sample of Korean adults 
who participated in KNHANES III in 2005, 
elevated blood cadmium levels were associated 
with lower eGFR levels in women but not in 
men. In women, a 2-fold increase in blood 
cadmium was associated with a statistically 
significant 1.51 mL/min per 1.73 m2 decrease 
in eGFR levels, with no difference by blood 
lead levels. In men, a 2-fold increase in blood 
cadmium was associated with a nonstatistically 
significant 0.68 mL/min per 1.73 m2 increase 
in eGFR levels, with possible effect modifica-
tion by lead levels: in men with blood lead 
≤ 2.75 μg/dL, a 2-fold increase in blood cad-
mium was associated with a non-statistically 
significant 1.14 mL/min per 1.73 m2 decrease 
in eGFR levels. In contrast, in men with 
blood lead > 2.75 μg/dL, a 2-fold increase in 
blood cadmium was associated with a statisti-
cally significant 1.84 mL/min per 1.73 m2 
increase in eGFR levels. These findings among 
men need to be interpreted cautiously as they 
were the result of a post hoc analysis with no 
a priori hypothesis for effect modification of 
the relation between cadmium and eGFR by 
lead levels.
Cadmium exposure in Asia (China, Japan, 
Korea) is generally higher than in Europe and 
the United States, because of the high number 
Table 2. Participant characteristics by sex and blood cadmium level.
Men Women
Blood cadmium tertile p-Value 
for trenda 
Blood cadmium tertile p-Value 
for trenda Characteristic Total < 1.29 μg/L  1.29–1.88  > 1.88 μg/L  Total < 1.29 μg/L 1.29–1.88 > 1.88 μg/L
n (%) 955 (100) 293 (30.3) 335 (34.9) 327 (34.8) 954 (100) 341 (36.4) 308 (31.9) 305 (31.7)
Age (years)b 42.2 (40.4, 44.0) 43.1 (41.2, 45.0) 43.1 (41.1, 45.1) 0.74 42.0 (40.2, 43.7) 43.5 (41.5, 45.6) 46.9 (45.2, 48.7) < 0.01
Postmenopause (%)c — — — — 332 31.2 31.9 36.9 0.06
Education (%)
< High school 235 25.0 35.7 39.3 0.11 384 30.7 29.1 40.2 < 0.01
High school 409 28.6 36.7 34.7 0.62 374 39.6 34.5 25.9 < 0.01
> High school 311 35.8 32.0 32.2 0.09 196 40.0 31.5 28.5 0.51
Region (%)
Metropolitan 356 36.1 30.9 33.0 < 0.05 413 37.1 32.6 30.3 0.72
Urban 391 27.2 38.9 33.9 0.25 332 37.5 30.1 32.4 0.80
Rural 208 23.5 35.8 40.7 0.27 209 32.9 32.7 34.4 0.61
BMI [ ≥ 25 kg/m2 (%)] 381 30.7 36.9 32.4 0.60 298 31.3 36.0 32.7 0.12
Smoking status (%)
Never 138 28.0 36.2 35.8 0.82 861 37.4 31.9 30.7 0.24
Former 343 35.7 34.3 30.0 < 0.05 42 34.9 28.6 36.5 0.81
Current 474 27.4 34.9 37.7 0.12 51 23.1 33.6 43.3 0.11
Alcohol intake (%)
Never 50 22.2 32.2 45.6 0.26 177 29.5 36.8 33.7 0.12
Former 86 23.3 30.6 46.1 0.17 112 35.6 32.9 31.5 0.97
Current 819 31.4 35.4 33.2 < 0.05 665 38.2 30.5 31.3 0.25
Blood lead (μg/dL)d 955 3.06 (2.89, 3.24) 3.00 (2.83, 3.18) 2.88 (2.64, 3.14) 0.51 954 2.35 (2.19, 2.53) 2.36 (2.18, 2.55) 2.22 (2.04, 2.41) 0.43
Diabetes mellitus (%) 87 40.6 31.0 28.4 0.17 54 34.3 22.6 43.1 0.17
Hypertension (%) 273 22.6 33.8 43.6 < 0.01 193 26.9 30.2 42.9 < 0.01
eGFR (mL/min/1.73 m2)b  955 80.1 (78.4, 81.8) 81.4 (80.0, 82.8) 80.3 (78.4, 82.2) 0.41 954 75.3 (73.5, 77.1) 73.1 (71.7, 74.5) 72.0 (70.5, 73.5) < 0.01
Reduced eGFR (%)e 262 33.4 34.1 32.5 0.56 259 28.7 32.1 39.2 < 0.01
—, data not available. All values are weighted. Tertiles are based on the weighted distribution in the whole study sample. 
ap-Value for trend estimated based on the Wald test. bMean (95% CI). cThere were 88 women with missing menopause status (n = 866). dGeometric mean (95% CI). eeGFR < 74.7 mL/min 
per 1.73 m2 for men and eGFR < 65.4 mL/min per 1.73 m2 for women. Cadmium and estimated glomerular filtration rate
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of cadmium–polluting industries and high 
intake of rice and vegetables grown locally 
in cadmium-contaminated soil (Nordberg 
et al. 2007). In KNHANES, blood cadmium 
levels were comparable to those found in the 
Japanese general population (geometric mean, 
1.76 μg/L) (Ikeda et al. 2000) and around 
four times higher than blood cadmium levels 
measured in the U.S. general population 
(geometric mean, 0.41 μg/L) (Navas-Acien 
et al. 2009) and in Swedish women (median, 
0.38 μg/L) (Åkesson et al. 2005). Also, 
although in the United States and other 
countries cadmium and lead are moderately 
correlated (Åkesson et al. 2005; Navas-Acien 
et al. 2009), in KNHANES cadmium and lead 
were not correlated, indicating that the sources 
of exposure for cadmium and lead could be 
different. For cadmium, diet is thought to be 
the main source of exposure for the general 
Korean population, whereas for lead the main 
source is thought to be ambient air (Eunha 
et al. 2006; Moon et al. 1995). In Korea, rice 
and barley samples from locations near mines 
or affected by mine drainage have shown 
significantly higher cadmium levels compared 
with samples from control areas (Kim et al. 
2008). High consumption of cadmium-
contaminated rice may explain higher 
cadmium levels in Korean adults compared 
with populations characterized by lower rice 
consumption (Kim and Lee 2011). Dietary 
sources of cadmium, however, are unlikely to 
explain the similar cadmium levels in men and 
women in KNHANES, compared with most 
other populations in which women tend to 
have higher cadmium levels. Higher smoking 
rates among men than among women could 
also result in more comparable blood cadmium 
levels in men and women than in other 
studies. Information on occupational exposure 
or job titles, unfortunately, was not available, 
and their relationship with cadmium levels in 
men and women could not be evaluated.
Early cadmium-induced kidney dam-
age is characterized by proximal tubule 
effects manifested by increased urinary excre-
tion of low-molecular-weight proteins such 
as β2-microglobulin (Nordberg et al. 2007). 
Tubular damage may progress to glomerular 
damage and eventually to kidney failure in the 
setting of high-level cadmium exposure (Järup 
et al. 1998; Jin et al. 2004). In animal stud-
ies, cadmium-treated rats showed enhanced 
glomerular filtration of proteins compared 
with controls, although cadmium levels used 
in these experiments were markedly higher 
compared with human populations (Bernard 
et al. 1992; Cardenas et al. 1992). Recently, 
a number of observational studies have shown 
adverse kidney effects at much lower cad-
mium levels (Åkesson et al. 2005; Hellström 
et al. 2001; Jin et al. 2004; Navas-Acien et al. 
2009; Thomas et al. 2009). In the U.S. general 
population, increasing blood cadmium   levels 
were associated with increased prevalences 
of albuminuria and eGFR < 60 mL/min per 
1.73 m2 (Navas-Acien et al. 2009).
In our study, despite similar blood cadmium 
levels in men and women, associations between 
blood cadmium and eGFR differed markedly 
by sex. In women, higher blood cadmium levels 
Table 3. Difference (95% CI) in eGFR levels (mL/min per 1.73 m2) by blood cadmium tertile.
Blood cadmium level (μg/L) n Model 1a Model 2b Model 3c
Men
< 1.29 293 0 (Reference) 0 (Reference) 0 (Reference)
1.29–1.88 335 1.24 (–0.83, 3.31) 1.32 (–0.44, 3.08) 1.38 (–0.37, 3.13)
> 1.88 327 0.50 (–1.70, 2.71) 0.42 (–1.41, 2.25) 0.67 (–1.16, 2.50)
Women
< 1.29 341 0 (Reference) 0 (Reference) 0 (Reference)
1.29–1.88 308 –2.59 (–4.71, –0.48) –1.92 (–3.73, –0.11) –1.94 (–3.73, –0.15)
> 1.88 305 –3.58 (–5.65, –1.52) –1.56 (–3.33, 0.20) –1.85 (–3.55, –0.16)
Tertiles are based on the weighted distribution in the whole study sample.
aNot adjusted (crude). bAdjusted for age, education, region (metropolitan, urban, rural), and BMI. cIncluded variables in 
model 2 and smoking status (never, former, current), alcohol intake (never, former, current), and blood lead (log micro-
grams per deciliter).
Table 4. Odds ratios (95% CIs) for reduced eGFRa by blood cadmium level.
Blood cadmium level (μg/L) Cases/non  cases Model 1b Model 2c Model 3d
Men
< 1.29 88/205 1 (Reference) 1 (Reference) 1 (Reference)
1.29–1.88 87/248 0.85 (0.56, 1.27) 0.76 (0.48, 1.20) 0.76 (0.48, 1.21)
> 1.88 87/240 0.80 (0.53, 1.21) 0.80 (0.52, 1.24) 0.75 (0.49, 1.15)
Women
< 1.29 75/266 1 (Reference) 1 (Reference) 1 (Reference)
1.29–1.88 86/222 1.37 (0.94, 1.99) 1.31 (0.82, 2.07) 1.30 (0.82, 2.08)
> 1.88 98/207 1.82 (1.25, 2.67) 1.49 (0.92, 2.40) 1.62 (1.00, 2.62)
Tertiles are based on the weighted distribution in the whole study sample.
aeGFR < 74.7 mL/min per 1.73 m2 for men and eGFR < 65.4 mL/min per 1.73 m2 for women. bNot adjusted (crude). cAdjusted 
for age, education, region (metropolitan, urban, rural), BMI. dIncluded variables in model 2 and smoking status (never, 
former, current), alcohol intake (never, former, current), and blood lead (log micrograms per deciliter).
Table 5. Difference (95% CI) in eGFR levels (milliliters per minute per 1.73 m2) comparing a 2-fold increase 
in blood cadmium by sex and other participant characteristics.
Men Women
Subgroup n Difference (95% CI)
p-Value for 
interactiona n Difference (95% CI)
p-Value for 
interactiona
Overall 955 0.68 (–0.47, 1.84) 954 –1.51 (–2.61, –0.40)
Age (years)
< 40 337 0.78 (–0.90, 2.46) 0.61 365 –2.46 (–4.16, –0.77) 0.06
40–60 456 0.72 (–1.19, 2.63) 411 –1.20 (–2.85, 0.46)
> 60 162 –1.53 (–5.07, 2.01) 178 0.11 (–2.40, 2.62)
BMI (kg/m2)
< 25 574 0.36 (–1.25, 1.96) 0.21 656 –1.81 (–3.10, –0.53) 0.65
≥ 25 381 1.11 (–0.66, 2.88) 298 –1.08 (–2.91, 0.75)
Education
< High school 235 –0.51 (–3.30, 2.28) 0.026 384 –0.30 (–2.04, 1.45) 0.13
High school 409 0.09 (–1.78, 1.96) 374 –2.38 (–3.88, –0.87)
> High school 311 2.27 (0.88, 3.66) 196 –2.18 (–4.27, –0.09)
Region
Metropolitan 356 0.53 (–1.21, 2.27) 0.51 413 –1.30 (–2.77, 0.16) 0.87
Urban 391 2.34 (0.40, 4.27) 332 –2.46 (–4.42, –0.50)
Rural 208 –2.45 (–5.42, 0.51) 209 –0.87 (–3.65, 1.91)
Smoking
Never 138 2.61 (0.25, 4.97) 0.18 861 –1.35 (–2.50, –0.21) 0.83
Former 343 0.14 (–2.07, 2.36) 42 –6.28 (–10.77, –1.78)
Current 474 0.38 (–1.23, 2.00) 51 0.41 (–3.12, 3.95)
Alcohol intake
Never 50 –6.78 (–14.61, 1.04) 0.052 177 –1.34 (–4.04, 1.35) 0.63
Former 86 0.58 (–3.93, 5.09) 112 –3.07 (–5.87, –0.27)
Current 819 1.19 (0.03, 2.35) 665 –1.51 (–2.66, –0.35)
Blood lead (μg/dL)
≤ 2.75 350 –1.14 (–3.35, 1.07) 0.048 567 –1.57 (–3.16, 0.01) 0.78
> 2.75 605 1.84 (0.54, 3.14) 387 –1.36 (–2.70, –0.01)
Adjustment included age, BMI, education level, region (metropolitan, urban, rural), smoking (never, former, current), 
drinking (never, former, current), and blood lead (log transformed). 
ap-Value for interaction was estimated including an interaction term between log-transformed blood cadmium and the 
corresponding group of categories.Hwangbo et al.
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were associated with lower eGFR, consistent 
with other cross-sectional studies on low-level 
cadmium exposure and clinical kidney disease 
measures (Åkesson et al. 2005; Navas-Acien 
et al. 2009) and supportive of cadmium as a 
CKD risk factor. The association in women 
was independent of blood lead levels. Some 
reports suggest that cadmium-related renal 
effects may be greater in women compared 
with men. For example, itai-itai disease, a com-
bination of kidney disease and bone damage, 
affected mainly women in cadmium-polluted 
areas in the Jinzu River of Toyama prefecture, 
Japan (Aoshima 1987; Kjellström et al. 1977; 
Nomiyama 1980). Although cadmium intake 
differed slightly between men and women, 
Nishijo et al. (2004) found that urine levels of 
cadmium, β2-microglobulin, and amino acids 
were higher in women than in men. In Sweden, 
after adjusting for age and sex, Hellström et al. 
(2001) reported that the risk of renal replace-
ment therapy was higher for cadmium-exposed 
participants than for unexposed participants 
and that the association between cadmium 
and renal replacement therapy was stronger 
among women than among men. Research in 
other populations and experimental models are 
needed to confirm hetero  geneity of cadmium 
effects by sex on the kidney and to identify the 
responsible mechanisms.
For the men in our study, however, 
cadmium levels were not associated with eGFR 
overall. For men with blood lead levels at or 
below the median, the findings were consistent 
with those in women, although the association 
was not statistically significant. Among men 
with higher blood lead levels, elevated cadmium 
levels were associated with higher eGFR. 
The explanation for the positive association 
between blood cadmium and eGFR levels 
among men with high lead levels observed in 
this study remains unclear. Previously, three 
studies reported positive associations between 
urine cadmium levels and glomerular filtration 
measures, although differences by gender were 
not evaluated. In the Cadmibel study (n = 
593), higher urine but not blood cadmium was 
prospectively associated with higher measured 
creatinine clearance in the 5-year follow-up, 
although the level of statistical significance was 
not reported (Hotz et al. 1999). In European 
children (n = 804), higher urine cadmium 
but not blood cadmium was cross-sectionally 
associated with lower serum creatinine after 
adjustment for other metals (de Burbure et al. 
2006). No association was found for urine or 
blood cadmium with serum β2-microglobulin 
or serum cystatin C (de Burbure et al. 2006). 
In that study, higher blood lead (> 55 μg/L; 
mean, 78.4 μg/L) was associated with lower 
serum creatinine, higher β2-microglobulin, 
and higher serum cystatin C, a finding that was 
consistent with hyperfiltration, an increase in 
GFR. Recently, in 712 Korean lead workers 
(mean urine cadmium, 1.15 μg/g creatinine), 
higher urine cadmium levels were associated 
with higher estimated creatinine clearance, 
eGFR, and N-acetyl-β-d-glucosaminidase 
levels and with lower serum creatinine after 
adjustment for sociodemographic and CKD 
risk factors, urine creatinine, and blood 
and bone lead levels (Weaver et al. 2011). 
Differences in the association between urine 
cadmium and kidney measures by blood 
lead levels were not evaluated, although lead 
exposure levels in this occupational population 
(mean blood lead, 23.1 μg/dL) were sub-
stantially higher than in our study.
The interaction between lead and cadmium 
with eGFR was a post hoc finding and not 
based on an a priori hypothesis. One potential 
explanation for the positive association between 
cadmium and eGFR among men exposed to 
higher lead levels is hyperfiltration, a process 
in which GFR is initially increased but may 
be followed by subsequent declines in GFR, 
leading to CKD. Glomerular hyperfiltration 
has been associated with early diabetes, obesity, 
and high-protein diet and has been suggested 
in lead workers (Bosch et al. 1983, 1984; 
Chagnac et al. 2000, 2003; Christiansen 1985; 
Friedman 2004; Mogensen 1986; Roels et al. 
1994; Tomaszewski et al. 2007; Weaver et al. 
2003). In our study, we could not evaluate 
the effect of early diabetes on the association 
between blood cadmium and eGFR because 
of the lack of information on diabetes onset. 
However, we also observed stronger positive 
associations between cadmium and eGFR in 
men with higher BMI, although those dif-
ferences were not statistically significant. In 
Korean lead workers, potential hyperfiltration 
associated with elevated blood lead was also 
found in younger workers, whereas in older 
workers blood lead levels were associated with 
worse renal function (Weaver et al. 2003).
There are several limitations to our study. 
First, we evaluated kidney function by estimat-
ing GFR instead of directly measuring it. GFR 
estimates may have greater inaccuracy in gen-
eral populations compared with CKD patients 
(Stevens et al. 2006). Moreover, the MDRD 
equation was developed in an adult popula-
tion from the United States (Beck et al. 1991; 
Kusek et al. 1993; Levey et al. 1999), and cur-
rently no correction is added based on Korean 
ethnicity. Compared with measured GFR 
using the 99mTc-DTPA (technetium=99m-
labeled diethylenetriamine pentaacetic acid) 
renal clearance method, precision and accu-
racy in 393 healthy Korean men and women 
were greater for the MDRD equation than for   
100/serum creatinine, 24-hr urine creatinine 
clearance, the Cockcroft-Gault equation, or 
the African-American Study of Kidney Disease 
and Hypertension equation (Kang et al. 
2005). Second, a single assessment of serum 
creatinine and blood cadmium was available. 
Urine cadmium, an established biomarker of 
chronic cadmium exposure, was not available. 
However, blood cadmium is a well-established 
biomarker of cadmium exposure. The half-life 
of blood cadmium is 3–4 months for a com-
ponent reflecting ongoing exposure, with a 
longer component of approximately 10 years 
reflecting equilibrium with internal body bur-
den (Järup and Åkesson 2009; Nordberg et al. 
2007). Thus, after chronic low-level exposure 
typical of the environmental setting and rele-
vant for this study, blood cadmium also indi-
cates body burden. Although blood cadmium 
reflects both ongoing and past exposure, non-
differential measurement error in cadmium 
exposure could potentially bias the results 
toward the null. Moreover, laboratory determi-
nation of cadmium can be challenging, and we 
cannot completely discard laboratory error as a 
source of bias in this study. Third, it is difficult 
to determine the directionality of the associa-
tion between blood cadmium and kidney func-
tion because this is a cross-sectional study. As 
a consequence, reverse causation cannot be 
excluded. Fourth, although the overall sample 
size was large, we found that the association of 
cadmium with eGFR differed by sex and pos-
sibly by lead levels in men. Because of the need 
to carry out subgroup analyses in men and 
women, our study may lack sufficient power 
to precisely estimate dose–response relation-
ships in subgroups and could be subject to 
biases due to multiple comparisons. As a conse-
quence, the sex and lead interactions described 
in this analy  sis will have to be confirmed in 
other studies. Strengths of the study include 
representation of the Korean population and 
the standardized study procedures.
Conclusion
We found that elevated blood cadmium levels 
were associated with lower eGFR in women, 
supporting the role of cadmium as a CKD 
risk factor. In men, there was no overall asso-
ciation between cadmium levels and eGFR. 
In men with high blood lead levels, however, 
elevated blood cadmium levels were associ-
ated with higher eGFR levels. In men with 
low blood lead levels, elevated blood cadmium 
levels were non-statistically associated with 
lower eGFR levels. Relatively few studies have 
examined the impact of low-level environmen-
tal cadmium exposure on glomerular filtra-
tion in general populations. Evaluating the 
consistency of the different directionality of 
the association between cadmium and eGFR 
by lead levels in men, and elucidating poten-
tial mechanisms for this finding if confirmed, 
could have important implications for risk 
assessment of cadmium-related kidney effects. 
Additional prospective studies and experimen-
tal work in animal   models are needed to fully 
understand the impact of low-level cadmium 
exposure on the kidney.Cadmium and estimated glomerular filtration rate
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